InFocus Capital Partners logo

InFocus Capital Partners

North America, New York, United States, Jericho

Description

InFocus Capital Partners provides seed and early round funding to life science companies, specifically within ophthalmology.

Investor Profile

InFocus Capital Partners has made 10 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Series A (60%)
  • Series B (20%)
  • Convertible Note (10%)
  • Seed (10%)

Country Focus

  • United States (80%)
  • United Kingdom (20%)

Industry Focus

  • Health Care
  • Therapeutics
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Market Research
  • Medical Device
  • Augmented Reality
  • Computer
  • Consumer Electronics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does InFocus Capital Partners frequently co-invest with?

Invest Michigan
North America, Michigan, United States, Detroit
Co-Investments: 1
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 2
Capital Community Angel Investors
North America, Michigan, United States, East Lansing
Co-Investments: 2
Techstart Ventures
Europe, Belfast, United Kingdom, Belfast
Co-Investments: 2
ExSight Ventures
North America, New York, United States, New York
Co-Investments: 5
QUBIS
Europe, Belfast, United Kingdom, Belfast
Co-Investments: 2
Aju IB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Yeoksamdong
Co-Investments: 2
Bios Partners
North America, Texas, United States, Fort Worth
Co-Investments: 2
Visionary Venture Fund
North America, California, United States, Aliso Viejo
Co-Investments: 2
Biosciences Research and Commercialization Center (BRCC)
North America, Michigan, United States, Kalamazoo
Co-Investments: 1

What are some of recent deals done by InFocus Capital Partners?

Re-Vana Therapeutics

Belfast, Belfast, United Kingdom

Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company.

Health CareMarket ResearchMedicalTherapeutics
Series ANov 30, 2022
Amount Raised: $12,075,997
Stuart Therapeutics

Stuart, Florida, United States

Stuart Therapeutics is a biotechnology company that offers PolyCol, a therapeutic platform for ophthalmic indications.

BiotechnologyHealth CareTherapeutics
Series AMar 19, 2021
Amount Raised: $11,000,000
ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BDec 22, 2020
Amount Raised: $46,900,000
Re-Vana Therapeutics

Belfast, Belfast, United Kingdom

Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company.

Health CareMarket ResearchMedicalTherapeutics
SeedJun 2, 2020
Amount Raised: $3,250,000
Mojo Vision

Saratoga, California, United States

Mojo develops high-performance micro-LED display technology with proprietary full-color quantum-dot technology with superior performance

Augmented RealityComputerConsumer Electronics
Series BApr 29, 2020
Amount Raised: $51,000,000
ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Convertible NoteAug 22, 2019
Amount Raised: $3,000,000
Trefoil Therapeutics

San Diego, California, United States

Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.

BiotechnologyHealth CareTherapeutics
Series AJul 16, 2019
Amount Raised: $28,000,000
Qura

Framingham, Massachusetts, United States

QURA develops a series of ultra-miniature implantable devices/tools to monitor physiological pressure changes.

Health CareMedical DeviceWearables
Series AJul 3, 2018
Amount Raised: $1,000,000
Alievio

Durham, North Carolina, United States

Alievio is a North Carolina-based innovative glaucoma medical device company.

Health CareMedicalMedical Device
Series AApr 10, 2018
Amount Raised: $5,700,000
Trefoil Therapeutics

San Diego, California, United States

Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.

BiotechnologyHealth CareTherapeutics
Series AJan 5, 2017
Amount Raised: $5,200,000